A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 3,600 shares of LMAT stock, worth $323,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,600
Previous 4,100 12.2%
Holding current value
$323,640
Previous $272,000 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.62 - $83.59 $475,786 - $635,116
7,598 Added 11.33%
74,664 $6.14 Million
Q1 2024

May 15, 2024

BUY
$54.0 - $71.06 $868,536 - $1.14 Million
16,084 Added 31.55%
67,066 $4.45 Million
Q4 2023

Feb 14, 2024

BUY
$45.37 - $58.41 $596,343 - $767,741
13,144 Added 34.74%
50,982 $2.89 Million
Q3 2023

Nov 14, 2023

SELL
$53.45 - $67.01 $2.79 Million - $3.5 Million
-52,286 Reduced 58.02%
37,838 $2.06 Million
Q2 2023

Aug 14, 2023

BUY
$50.38 - $68.21 $3.19 Million - $4.31 Million
63,245 Added 235.3%
90,124 $6.06 Million
Q1 2023

May 15, 2023

BUY
$44.73 - $51.68 $1.2 Million - $1.39 Million
26,879 New
26,879 $1.38 Million
Q3 2022

Nov 14, 2022

BUY
$45.29 - $55.99 $1.32 Million - $1.63 Million
29,049 Added 211.91%
42,757 $2.17 Million
Q2 2022

Aug 15, 2022

SELL
$39.05 - $47.85 $1.59 Million - $1.95 Million
-40,679 Reduced 74.8%
13,708 $624,000
Q1 2022

May 16, 2022

BUY
$40.48 - $51.5 $1.69 Million - $2.14 Million
41,649 Added 326.97%
54,387 $2.53 Million
Q4 2021

Feb 14, 2022

SELL
$46.66 - $56.25 $2.48 Million - $2.99 Million
-53,186 Reduced 80.68%
12,738 $639,000
Q3 2021

Nov 15, 2021

BUY
$53.09 - $60.57 $2.18 Million - $2.49 Million
41,055 Added 165.09%
65,924 $3.5 Million
Q2 2021

Aug 16, 2021

SELL
$47.74 - $63.33 $501,508 - $665,281
-10,505 Reduced 29.7%
24,869 $1.52 Million
Q1 2021

May 17, 2021

SELL
$40.19 - $51.5 $2.58 Million - $3.31 Million
-64,313 Reduced 64.51%
35,374 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$31.44 - $41.27 $2.12 Million - $2.79 Million
67,570 Added 210.39%
99,687 $4.04 Million
Q3 2020

Nov 16, 2020

BUY
$25.73 - $33.98 $282,618 - $373,236
10,984 Added 51.98%
32,117 $1.05 Million
Q2 2020

Aug 14, 2020

SELL
$22.88 - $30.71 $158,878 - $213,250
-6,944 Reduced 24.73%
21,133 $558,000
Q1 2020

May 15, 2020

SELL
$21.03 - $38.46 $1.05 Million - $1.92 Million
-50,003 Reduced 64.04%
28,077 $700,000
Q4 2019

Feb 14, 2020

SELL
$31.27 - $36.21 $261,542 - $302,860
-8,364 Reduced 9.68%
78,080 $2.81 Million
Q3 2019

Nov 14, 2019

SELL
$27.91 - $35.78 $652,200 - $836,107
-23,368 Reduced 21.28%
86,444 $2.95 Million
Q2 2019

Aug 14, 2019

BUY
$25.55 - $30.79 $6,821 - $8,220
267 Added 0.24%
109,812 $3.07 Million
Q1 2019

May 15, 2019

SELL
$22.45 - $31.55 $1.12 Million - $1.57 Million
-49,686 Reduced 31.2%
109,545 $0
Q4 2018

Feb 14, 2019

BUY
$22.01 - $37.23 $921,272 - $1.56 Million
41,857 Added 35.66%
159,231 $3.76 Million
Q3 2018

Nov 13, 2018

SELL
$34.02 - $38.74 $1.44 Million - $1.64 Million
-42,424 Reduced 26.55%
117,374 $0
Q2 2018

Aug 10, 2018

BUY
$31.45 - $41.02 $4.82 Million - $6.28 Million
153,152 Added 2304.42%
159,798 $0
Q1 2018

May 11, 2018

BUY
$30.5 - $37.13 $202,703 - $246,765
6,646 New
6,646 $241,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $1.97B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.